Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy - Ge, Yi; Liu, Xiaoyu; Xu, Yishi; Su, Yanwei; Li, Yixin; Wang, Liping (Frontiers in Oncology, 2024)